title: [Fondaparinux and lepirudin as therapeutic alternatives in a disseminated eczematous skin reaction to low-molecular-weight heparin].
authors.forename: D I
authors.initials: DI
authors.lastname: Santiago Sánchez-Mateos
authors.forename: C
authors.initials: C
authors.lastname: Eguren
authors.forename: D
authors.initials: D
authors.lastname: de Argila
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-Pérez
mesh_terms: D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006629:Hirudins; D011134:Polysaccharides; D011994:Recombinant Proteins; D000077425:Fondaparinux; C083544:lepirudin